Figure 11.
(a) Representative micro-computed tomography images of the bone defects implanted with CLF hydrogel containing different concentrations of BMP-2 (0, 0.5, 1, 2, or 5μg) at 4 weeks. (b) Quantification of regenerated bone volume within the bone defects. * denotes significant difference compared to the control CLF hydrogel groups with 0 μg BMP-2 (p<0.05).